$7.29
1.49% yesterday
Nasdaq, May 20, 10:00 pm CET
ISIN
IE00B91XRN20
Symbol
PRTA
Sector
Industry

Prothena Corp. Plc Stock price

$7.29
-2.01 21.61% 1M
-7.11 49.38% 6M
-6.56 47.36% YTD
-15.34 67.79% 1Y
-19.79 73.08% 3Y
-4.04 35.66% 5Y
-26.52 78.44% 10Y
Nasdaq, Closing price Tue, May 20 2025
-0.11 1.49%
ISIN
IE00B91XRN20
Symbol
PRTA
Sector
Industry

Key metrics

Market capitalization $392.40m
Enterprise Value $-15.34m
P/E (TTM) P/E ratio negative
EV/FCF (TTM) EV/FCF 0.12
EV/Sales (TTM) EV/Sales -0.11
P/S ratio (TTM) P/S ratio 2.84
P/B ratio (TTM) P/B ratio 0.90
Revenue growth (TTM) Revenue growth 54.55%
Revenue (TTM) Revenue $137.94m
EBIT (operating result TTM) EBIT $-138.61m
Free Cash Flow (TTM) Free Cash Flow $-128.51m
Cash position $417.94m
EPS (TTM) EPS $-2.08
P/E forward negative
P/S forward 8.34
EV/Sales forward negative
Short interest 26.05%
Show more

Is Prothena Corp. Plc a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,789 stocks worldwide.

Prothena Corp. Plc Stock Analysis

Unlock Scores for Free

Analyst Opinions

10 Analysts have issued a Prothena Corp. Plc forecast:

8x Buy
80%
2x Hold
20%

Analyst Opinions

10 Analysts have issued a Prothena Corp. Plc forecast:

Buy
80%
Hold
20%

Financial data from Prothena Corp. Plc

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Mar '25
+/-
%
138 138
55% 55%
100%
- Direct Costs 3.61 3.61
81% 81%
3%
134 134
92% 92%
97%
- Selling and Administrative Expenses 60 60
123% 123%
44%
- Research and Development Expense 209 209
13% 13%
152%
-135 -135
31% 31%
-98%
- Depreciation and Amortization 3.61 3.61
81% 81%
3%
EBIT (Operating Income) EBIT -139 -139
36% 36%
-100%
Net Profit -110 -110
36% 36%
-80%

In millions USD.

Don't miss a Thing! We will send you all news about Prothena Corp. Plc directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Prothena Corp. Plc Stock News

Neutral
Business Wire
12 days ago
DUBLIN--(BUSINESS WIRE)---- $PRTA #prothena--Prothena today reported financial results for the first quarter of 2025 and provided business highlights.
Neutral
Business Wire
19 days ago
DUBLIN--(BUSINESS WIRE)---- $PRTA #prothena--Prothena today announced that it will report its first quarter 2025 financial results on Thursday, May 8, 2025.
Neutral
Seeking Alpha
3 months ago
Prothena Corporation plc (NASDAQ:PRTA ) Q4 2024 Earnings Conference Call February 20, 2025 4:30 PM ET Company Participants Mark Johnson - Vice President of Investor Relations Gene Kinney - President and Chief Executive Officer Chad Swanson - Chief Development Officer Tran Nguyen - Chief Financial Officer and Chief Strategy Officer Brandon Smith - Chief Operating Officer Conference Call Particip...
More Prothena Corp. Plc News

Company Profile

Prothena Corp. Plc is a clinical-stage neuroscience company. It focuses on the discovery and development of novel therapies to change the course of devastating diseases. The company was founded in December 1969 and is headquartered in Dublin, Ireland.

Head office Ireland
CEO Gene Kinney
Employees 163
Founded 1969
Website www.prothena.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today